Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 30.06.2025
Swissnet AG
swissnet Group publishes audited FY 2024 financial statements and management report
Berg, Switzerland – 30 June 2025 – The swissnet Group (ISIN: CH0451123589 – Ticker: MLBMD), a leading provider of ICT solutions today announced the publication of its audited financial statements and management report for the full year 2024. swissnet Group has prep [ … ]
Mon, 30.06.2025
AUSTRIACARD HOLDINGS AG
EQS-Media / 30.06.2025 / 16:55 CET/CEST
AUSTRIACARD HOLDINGS AG announced changes to its Supervisory Board following the Annual General Meeting
June 30, 2025 - AUSTRIACARD HOLDINGS AG (“ACAG” or the “Company”), an international applied technology group headquartered in Vienna and listed in the Athens and Vienna Stock Exchanges under the [ … ]
Mon, 30.06.2025
Viromed Medical AG
Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026
Pinneberg, June 30, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, expects dynamic sales growth in the coming financial years. In detail, revenue is expected to rise from EUR 1.37 milli [ … ]
Mon, 30.06.2025
CENTROTEC SE
30.06.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
Mon, 30.06.2025
Jaguar Health Inc
Company Name:
Jaguar Health Inc
ISIN:
US47010C8055
Reason for the research:
Update
Recommendation:
Buy
from:
30.06.2025
Target price:
USD40
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Jaguar Health, Inc. (ISIN: US47010C8055 [ … ]
Mon, 30.06.2025
invIOs GmbH
invIOs reports promising Phase 1b results for cell therapy APN401 in advanced solid tumors
Successful completion of the multi-center trial with autologous cell therapy APN401 marks a key step forward toward clinical use.
APN401 shows a favorable safety profile and promising efficacy signals in patients with late-stage solid tumors.
The observed [ … ]
Mon, 30.06.2025
Eurobattery Minerals AB
EQS-Media / 30.06.2025 / 13:35 CET/CEST
Stockholm, 30 June 2025 – The mining company Eurobattery Minerals AB (Nordic Growth Market: “BAT” and Börse Stuttgart: “EBM”; in short: “Eurobattery Minerals” or the “Company”) informs that the annual general meeting 2025 in the Company was held today, 30 June 2025, whereby the shareholders passed the f [ … ]
Mon, 30.06.2025
Circus SE
Circus SE publishes 2024 Annual Report marking the completion of the R&D phase
Munich, June 30, 2025 – Circus SE (XETRA: CA1) today published its audited financial results for fiscal year 2024, reflecting a highly successful year in the industrialization of the CA-1 robot. The company expects a positive outlook as it transitions from research [ … ]
Mon, 30.06.2025
ParTec AG
Company Name:
ParTec AG
ISIN:
DE000A3E5A34
Reason for the research:
Update
Recommendation:
Under Review
from:
30.06.2025
Target price:
Under Review
Target price on sight of:
12 months
Last rating change:
30.06.2025 (previously: Buy)
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on ParTec A [ … ]
Mon, 30.06.2025
Bilfinger SE
Bilfinger SE: Share Buyback
Disclosure according to Art. 5 para. 1(b), para 3 of Regulation (EU) No. 596/2014 in connection with Art. 2 para. 2 and 3 of Delegated Regulation (EU) 2016/1052
Share buyback – 23. Interim Reporting
In the time period from June 23, 2025 until and including June 27, 2025, a number of 13,597 shares were bought back wit [ … ]